No description available.

No description available.

No description available.

No description available.

No description available.

Phytoöstrogene sind in den vergangenen Jahren zunehmend in den Fokus der Wissenschaft gerückt, weil sie eine potentielle Alternative zur klassischen Hormonersatztherapie darstellen. Diese ist aufgrund von zum Teil drastischen Nebenwirkungen für den Einsatz von klimakterischen Beschwerden umstritten. In dieser Arbeit wird die dosisabhängige Wirkung des Phytoöstrogens Genistein an ausgewählten östrogenselektiven Organen näher untersucht. Die Versuche wurden am Modell der langzeitovarektomierten Maus durchgeführt. Es wurden 70 ovarektomierte Tiere in sieben Gruppen aufgeteilt und untersucht. Fünf der sieben Gruppen erhielten genisteinhaltiges Futter in verschiedenen Konzentrationen. Die anderen beiden Gruppen erhielten Estradiol als Zusatz oder sojafreie Diät und dienten jeweils als Positiv- und Negativkontrollgruppe. Zusätzlich gab es eine nicht ovarektomierte intakte Kontrollgruppe, die ebenfalls sojafreies Futter erhielt. Während des dreimonatigen Versuchszeitraums wurden regelmäßig Gewicht und Futterverbrauch der Tiere gemessen. Nach Ende des Versuchs wurden die Feuchtgewichte von Uterus und Herz bestimmt sowie die Genexpression am linken Ventrikel von IGF-1, ERα und Myocardin mittels PCR analysiert. Darüber hinaus wurde am Tibia-Knochen per pQCT die Messung der Spongiosadichte, des polaren Widerstandsmoments und des prozentualen Anteils der Trabekel an der Spongiosaquerschnittsfläche durchgeführt. Die Ergebnisse zeigen, dass Genistein direkt am Herz wirkt, indem es das relative Herzgewicht und die Genexpression am Herz erhöht. Genistein beeinflusst auch das Körpergewicht und das relative Gewicht des Uterus und die untersuchten Knochenparameter dosisabhängig. Genistein kann in höherer Dosierung am Uterus proliferierend wirken, jedoch nach derzeitigem Kenntnisstand weniger stark als der klassische Hormonersatztherapie-Wirkstoff E2. Genistein kann zukünftig nur dann eine Therapiealternative zur klassischen Hormonersatztherapie darstellen, wenn es gelingt, eine Dosis zu finden, bei der Genistein die gewünschten Wirkungen entfaltet, gleichzeitig aber die unerwünschte proliferierende Wirkung an Brust und Uterus sicher ausgeschlossen werden kann. Im Modell der ovarektomierten Maus scheint eine Dosis von 1 g/kg Genistein im Futter ein vielversprechender Ansatzpunkt für weitere Untersuchungen zu sein.

The aim of my work was to monitor and valorize of postnatal dynamics of thyroid hormones, thyroxine (TT4), triiodothyronine (TT3) and its free fractions (FT3 and FT4), in lambs up to 60 days of age. During the experiment 26 lambs were devided into two groups according to sex and were supplemented by iodine in concentration 0,7 ? 5 mg. Standard directed day ration for sheep is average 0,3 mg of iodine in 1 kilogram of dry mass (DM). One of the groups was also supplemented by selenium in concentration 0,2 ? 0,4 mg in 1 kilogram of DM.

Emotion, as well as cognition, are often understood as a manifestation of brain activity. However, bodily processes are also involved in mental functioning, referring to the concept of embodiment. Embodied emotion, traditionally, implies that experiencing an emotion involves perceptual, somato-visceral, and motor aspects. Within the frame of the Research Training Group “Situated Cognition”, we here extend the concept of embodiment by considering the role of hormones in the processing of emotional content. Importantly, hormones allow a bidirectional body-to-brain and brain-to-body coupling. The endocrine system, e.g., steroid sex hormones, produced in the gonads, send feedback to the brain by binding at their receptors. These receptors are relatively abundant in the brain regions associated with emotional processing, memory, and executive functions (i.e., amygdala, hippocampus, and prefrontal cortex). Moreover, peripheral hormone secretion is modulated via actions from the central nervous system. We intended to characterize the role of sex hormones, and partly also of stress hormones, on different components of emotion as a hormonal embodiment of emotion. Thus, we examined emotional processing in different sex hormone-status groups. To account for different levels of sex hormones, we used a quasi-experimental approach by comparing women in different cycle phases, women using hormonal oral contraceptives (Study 1), and additionally men (in Study 2). The female menstrual cycle is characterized by fluctuating sex hormone levels. On the peripheral gonadal level, these are 17β-estradiol and progesterone. These hormones are low at the beginning of the cycle (early follicular phase). Estradiol rises towards the middle of the cycle (mid-cycle) and stays moderately high until the next cycle. Progesterone levels are high after mid-cycle in the luteal phase until the end of the cycle. Hormonal contraceptives suppress the endogenous production of estradiol and progesterone, keeping the hormone levels low during the whole cycle. Estradiol and progesterone are also present in males, however, at low levels with no sign of cyclical fluctuations. In Study 1, we examined three independent groups of women in the mid-cycle (n = 24), in the luteal phase (n = 24), and women using hormonal oral contraceptives (n = 24). We assessed different measures of emotional processing, i. e. emotional memory, cognitive and affective empathy-related measures (emotion recognition and ratings for feeling with a protagonist´s emotion, respectively), as well as mimic and skin-conductance responses to affective stimuli. Additionally, we addressed interactions of experimental stress (cold pressor test vs. control) with sex hormones in emotional memory. Our data demonstrated the role of hormones in empathy-related measures and skin-conductance responses depending on the stimulus characteristics (valence, the gender of the protagonist). Emotional memory was not affected by hormone status, stressor or salivary hormone levels. In the cognitive empathy-related measure, women in the luteal phase, as well as oral contraceptive users, identified emotions depicted by female protagonists more accurately than those by male protagonists. On the other hand, estradiol correlated positively with recognition of emotions depicted by males in the total sample. In the affective empathy-related measure, oral contraceptive users rated negative emotions higher than the positive ones. Finally, in the luteal phase skin-conductance responses to negative stimuli were heightened, also supported by a positive correlation with the salivary progesterone levels. The mimic responses remained unaffected. None of the remaining associations with the salivary hormone levels were significant. These results indicate that sex hormones modulated emotional processing by interacting with the stimulus features, as evident in the negativity bias under oral contraceptive use and in the luteal phase in the affective empathy-related measure and sympathetic autonomous reactivity, respectively. However, emotional memory and mimic activity to affective stimuli were not affected. In Study 2, we extended the initial scope to examine the role of sex hormones and olfaction in empathy-related measures. Reports of female advantage in empathy-related measures suggest a role for sex hormones, although data are inconsistent. Studies also report similar sex differences in human olfactory perception. In rodents, olfaction is involved in detecting and integrating socially-relevant information and is modulated by the brain-actions of estrogens. Based on this background, we hypothesized that olfaction may untangle the mixed evidence regarding the relationship between sex hormones and empathy-related measures (cognitive, affective). Thus, we measured odor discrimination ability, empathy-related measures, and facial mimic activity (also associated with affective empathy-related measures) in free-cycling women in high sex-hormone phases (n = 20), oral contraceptive users (n = 19), and men (n = 21). Free-cycling women outperformed only men in the recognition of emotions depicted from the eye region. Oral contraceptive users showed higher scores in the affective empathy-related measure towards negative emotions. Free-cycling women exhibited the strongest facial mimicry (viewing female, but not male protagonists), positively associated with progesterone. Finally, the groups differed in odor discrimination, with free-cycling women outperforming men. However, odor discrimination ability and empathy-related performance were not correlated. Our results support the role of sex hormones in odor perception and empathy-related measures, to a certain extent. However, no common underlying mechanism was found. Finally, we conducted a systematic review (Study 3) aiming to elucidate factors contributing to the inconsistent results concerning the role of sex hormones in the two most addressed areas of emotional processing, emotion recognition (empathy-related measure) and emotional memory. Thereby, we extended previous reviews that address single areas of emotion processing. Moreover, we systematically addressed the role of situational features (mainly emotion-type and/or stimulus valence). All studies included healthy women of reproductive age either in stages of their natural menstrual cycle or using oral contraceptives, and measured or at least estimated levels of ovarian sex hormones. We document the methodological diversity in the field, presumably contributing to the heterogeneity of results. We recognized the need for studies explicitly contrasting the early follicular, mid-cycle, and mid-luteal phases, as well as OC-intake and using standardized tasks. Research would take advantage of using within-subject design more frequently and account for the recognition of complex emotions. In sum, our data suggest that sex hormones differentially modulate the cognitive and affective empathy-related performance and skin-conductance responses by interacting with situational variables, such as the emotional valence of the stimuli and the gender of the protagonist. Women in the luteal phase and under oral contraceptive use demonstrated better recognition of emotions depicted by female protagonists. By contrast, estradiol levels positively correlated with the recognition of emotions depicted by male protagonists. Sex-hormone status main effects only manifested in the emotion recognition advantage of free-cycling women over men (Reading the Mind in The Eyes Test; Study 2). In both studies, affective empathy ratings towards negative emotions were higher in the oral contraceptive users. Moreover, although mimic activity was not associated with sex hormones, skin-conductance responses to negative stimuli were heightened in the luteal phase. On the other hand, the performance in empathy-related measures in different hormone-status groups was not related to odor discrimination ability. Additionally, the inconsistencies of the sex hormone and emotion research could be the result of variations of designs and tasks used across studies from a similar field. This is also indicated in our findings from the empathy-related measures differing in tasks and hormone-status groups in two studies. Finally, our findings provide evidence that emotional processes under sex-hormone modulation are situated, i.e., subject to the influence of the stimulus valence. Furthermore, they are embodied via coupling between the endocrine system and the brain as evident in hormone status and valence interactions in empathy-related measures and sympathetic reactivity.

Künstliches Licht in der Nacht (ALAN) entsteht in Zentren menschlicher Aktivität und erhellt die Nacht, wodurch biologische Rhythmen von Menschen und Wildtieren gestört werden können. Skyglow ist eine diffuse Aufhellung des Nachthimmels aufgrund von Reflexion und Streuung von ALAN, welche indirekt große Bereiche (vor-)städtischer Ökosysteme beleuchtet. Da sich Zentren menschlicher Aktivität häufig in der Nähe von Flüssen und Seen befinden, kann sich Skyglow unverhältnismäßig stark auf wildlebende Tiere in Süßwassergebieten auswirken. In drei Experimenten wurden die Auswirkungen von ALAN auf die Physiologie des Europäischen Flussbarsches untersucht. Die Fische wurden verschiedenen Versuchsbedingungen ausgesetzt: 1) niedrige ALAN-Intensitäten von 0,01, 0,1 und 1 lx unter kontrollierten Bedingungen, 2) höhere ALAN-Intensitäten von 1, 10 und 100 lx unter kontrollierten Bedingungen und 3) eine niedrige ALAN-Intensität von 0,06 lx in einem Feldexperiment. In den vorgestellten Experimenten unterdrückten niedrige ALAN-Intensitäten den nächtlichen Melatoninspiegel sowie teilweise Reproduktionshormone bei Weibchen. Höhere ALAN-Intensitäten verringerten das aktivste Schilddrüsenhormon und das relative Lebergewicht der Fische. Diese Arbeit zeigt physiologische Veränderungen bereits bei schwachen ALAN-Intensitäten, wie sie in großen Bereichen (vor-)städtischer Ökosysteme in Form von Skyglow vorkommen. Die empfindlichste Reaktionsvariable auf die Belastung durch ALAN bei Fischen ist der nächtliche Melatoninspiegel. Mögliche Wirkungen von ALAN auf andere physiologische Parameter können durch direkten Lichteinfall oder indirekt über reduziertes Melatonin ausgelöst werden. Diese Arbeit trägt zum Verständnis der Schwellenwerte für verschiedene physiologische Effekte durch eine mehrwöchige ALAN-Exposition bei. Schwellenwerte für ALAN-Intensitäten könnten zukünftig notwendige Deskriptoren für die Ausarbeitung von regulierenden Maßnahmen zur Reduzierung von Lichtverschmutzung liefern. / Artificial light at night (ALAN) is emitted from centers of human activities and increasingly brightens up nights, which can disturb biological rhythms of humans and wildlife. Skyglow is a diffuse brightening of the night sky due to reflection and scattering of ALAN, which indirectly illuminates large areas of (sub-)urban ecosystems. As centers of human activities are usually located close to rivers and lakes, skyglow may disproportionally affect wildlife of freshwater. Three experiments tested for effects of ALAN on the physiology of Eurasian perch. Fish were exposed 1) to low nocturnal illuminances of 0.01, 0.1 and 1 lx under controlled conditions, 2) to higher nocturnal illuminances of 1, 10 and 100 lx under controlled conditions, and 3) to low nocturnal illuminance of 0.06 lx in a field experiment. In the presented experiments, low nocturnal illuminance suppressed nocturnal melatonin production and reduced reproductive hormones to some extent in females. Higher nocturnal illuminance reduced the most active thyroid hormone and reduced relative liver weight of the fish. This thesis shows physiological changes already at very weak intensities of ALAN, like they occur over large areas of (sub-)urban ecosystems in the form of skyglow. The most sensitive response variable to ALAN exposure is the nocturnal melatonin levels. Possible actions of ALAN on other physiological parameters can be either by direct perception of light or indirectly via reduced melatonin. This thesis contributes to an understanding of thresholds for several physiological effects caused by ALAN exposure of several weeks. Thresholds for ALAN intensities could provide the necessary descriptors for elaborating regulatory measures to reduce light pollution in the future.

No description available.